Presentation is loading. Please wait.

Presentation is loading. Please wait.

Full hematopoietic engraftment after allogeneic bone marrow transplantation without cytoreduction in a child with severe combined immunodeficiency by Ronald.

Published bySteven Gibson Modified over 5 years ago

Similar presentations

Presentation on theme: "Full hematopoietic engraftment after allogeneic bone marrow transplantation without cytoreduction in a child with severe combined immunodeficiency by Ronald."— Presentation transcript:

1 Full hematopoietic engraftment after allogeneic bone marrow transplantation without cytoreduction in a child with severe combined immunodeficiency by Ronald J. Rubocki, Jennifer R. Parsa, Michael S. Hershfield, Warren G. Sanger, Samuel J. Pirruccello, Ines Santisteban, Bruce G. Gordon, Sarah E. Strandjord, Phyllis I. Warkentin, and Peter F. Coccia Blood Volume 97(3): February 1, 2001 ©2001 by American Society of Hematology

2 Graphic representation of hematologic parameters and engraftment status at selected times after bone marrow transplantation.Blood components (absolute lymphocyte count [ALC], absolute neutrophil count [ANC], platelets) and hemoglobin values are shown in the... Graphic representation of hematologic parameters and engraftment status at selected times after bone marrow transplantation.Blood components (absolute lymphocyte count [ALC], absolute neutrophil count [ANC], platelets) and hemoglobin values are shown in the lower panel. Percentage donor cells analyzed by cytogenetics in the recipient after transplantation are shown in the top panel. A specific 1qh+ polymorphism was detected in the recipient before BMT. At 1 and 3 months after BMT, analysis of PHA-stimulated PBLs demonstrated mixed chimerism. Full donor engraftment was found at 6 months, and all subsequent findings of PBLs and BM (at 1 and 8 years) have remained 100% of donor origin. Ronald J. Rubocki et al. Blood 2001;97: ©2001 by American Society of Hematology

Download ppt "Full hematopoietic engraftment after allogeneic bone marrow transplantation without cytoreduction in a child with severe combined immunodeficiency by Ronald."

Similar presentations

Prevention of graft-versus-host disease by anti–IL-7Rα antibody by Brile Chung, Eric P. Dudl, Dullei Min, Lora Barsky, Nancy Smiley, and Kenneth I. Weinberg.

Prevention of graft-versus-host disease by anti–IL-7Rα antibody by Brile Chung, Eric P. Dudl, Dullei Min, Lora Barsky, Nancy Smiley, and Kenneth I. Weinberg.
Evidence of B Cell Immune Responses to Acute Lymphoblastic Leukemia in Murine Allogeneic Hematopoietic Stem Cell Transplantation Recipients Treated with.

Evidence of B Cell Immune Responses to Acute Lymphoblastic Leukemia in Murine Allogeneic Hematopoietic Stem Cell Transplantation Recipients Treated with.
Brain Pop Analyzing the video clip.

Brain Pop Analyzing the video clip.
Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors.

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors.
Unique patterns of surface receptors, cytokine secretion, and immune functions distinguish T cells in the bone marrow from those in the periphery: impact.

Unique patterns of surface receptors, cytokine secretion, and immune functions distinguish T cells in the bone marrow from those in the periphery: impact.
Bystander destruction of hematopoietic progenitor and stem cells in a mouse model of infusion-induced bone marrow failure by Jichun Chen, Karen Lipovsky,

Bystander destruction of hematopoietic progenitor and stem cells in a mouse model of infusion-induced bone marrow failure by Jichun Chen, Karen Lipovsky,
MBL: mostly benign lymphocytes, but…

MBL: mostly benign lymphocytes, but…
Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene by A.

Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene by A.
Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study.

Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study.
In utero transplantation may soon be in delivery

In utero transplantation may soon be in delivery
Gupta V, Tallman MS, Weisdorf DJ

Gupta V, Tallman MS, Weisdorf DJ
Evidence for increased risk of secondary graft failure after in vivo depletion of suicide gene-modified T lymphocytes transplanted in conjunction with.

Evidence for increased risk of secondary graft failure after in vivo depletion of suicide gene-modified T lymphocytes transplanted in conjunction with.
Successful Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplant in an Acute Leukemia Patient With Chemotherapy-Induced Marrow Aplasia and Progressive.

Successful Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplant in an Acute Leukemia Patient With Chemotherapy-Induced Marrow Aplasia and Progressive.
Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants by.

Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants by.
by Alexis S. Bailey, Shuguang Jiang, Michael Afentoulis, Christina I

by Alexis S. Bailey, Shuguang Jiang, Michael Afentoulis, Christina I
Continuous in vivo infusion of interferon-gamma (IFN-γ) enhances engraftment of syngeneic wild-type cells in Fanca–/– and Fancg–/– mice by Yue Si, Samantha.

Continuous in vivo infusion of interferon-gamma (IFN-γ) enhances engraftment of syngeneic wild-type cells in Fanca–/– and Fancg–/– mice by Yue Si, Samantha.
Clinical response to F16-IL2 and LDAC in patients with AML bone marrow involvement. Clinical response to F16-IL2 and LDAC in patients with AML bone marrow.

Clinical response to F16-IL2 and LDAC in patients with AML bone marrow involvement. Clinical response to F16-IL2 and LDAC in patients with AML bone marrow.
Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program by Michael.

Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program by Michael.
Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte.

Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte.
Adoptive immunotherapy in canine mixed chimeras after nonmyeloablative hematopoietic cell transplantation by George E. Georges, Rainer Storb, Jennifer.

Adoptive immunotherapy in canine mixed chimeras after nonmyeloablative hematopoietic cell transplantation by George E. Georges, Rainer Storb, Jennifer.

Similar presentations

Ads by Google